Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sickinger

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Physical Review. E|November 15, 2016
Tunable φ Josephson junction ratchetR Menditto, H Sickinger, M Weides, et al.
Physical Review Letters|September 26, 2012
Experimental evidence of a φ Josephson junctionH Sickinger, A Lipman, M Weides, et al.
Psychological Medicine|September 7, 2002
Personality disorders and depressionM Fava, A H Farabaugh, A H Sickinger, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorderRoy H Perlis, Andrew A Nierenberg, Jonathan E Alpert, et al.
Psychosomatics|August 22, 2002
Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorderShamsah B Sonawalla, George I Papakostas, Timothy J Petersen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Physical Review. E|November 15, 2016
Tunable φ Josephson junction ratchetR Menditto, H Sickinger, M Weides, et al.
Physical Review Letters|September 26, 2012
Experimental evidence of a φ Josephson junctionH Sickinger, A Lipman, M Weides, et al.
Psychological Medicine|September 7, 2002
Personality disorders and depressionM Fava, A H Farabaugh, A H Sickinger, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorderRoy H Perlis, Andrew A Nierenberg, Jonathan E Alpert, et al.
Psychosomatics|August 22, 2002
Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorderShamsah B Sonawalla, George I Papakostas, Timothy J Petersen, et al.
Pageof 1